Tianjin, China

Guoping Wang

This inventor holds 1 USPTO granted patent. Top assignees: Aurisco Pharmaceutical (Tianjin) Inc., Aurisco Pharmaceutical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guoping Wang. Retrieved from https://idiyas.com/inventor/guoping-wang-cem2obit

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guoping Wang: Pharmaceutical Chemistry Inventor

Introduction

Guoping Wang is an inventor associated with Tianjin, China. His patent work focuses on a thienopyrimidine compound and a preparation method intended to support production of a high-purity product.

Latest Patents

Wang is associated with 1 patent: “High-purity thienopyrimidine compound and preparation method therefor.” The patent describes preparing a thienopyrimidine compound through a two-step process. First, a compound of formula N-2 reacts with 3-amino-6-methoxypyridazine in a solvent, with an organic base and acyl chloride, to produce a compound of formula N-1. Next, a base converts the intermediate into the target compound of formula N.

The described method avoids toxic and expensive reagents and uses mild reaction conditions. It is also reported to produce high-purity material and to be suitable for industrial production.

Career Highlights

Wang is associated with Aurisco Pharmaceutical (Tianjin) Inc. and Aurisco Pharmaceutical Co., Ltd. His patent reflects work on a practical preparation process for a pharmaceutical compound.

Collaborations

Wang’s listed coworkers include Wancheng Guo and Fuchang Zhang.

Conclusion

Guoping Wang’s patent centers on a streamlined method for preparing a high-purity thienopyrimidine compound, with features intended to support industrial-scale production.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…